Allergan
Pharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Allergan?
Summarize this article for a 10 year old
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology.[1][2][3] The company is the maker of Botox.[1]
Company type | Subsidiary |
---|---|
NYSE: AGN | |
Industry | Pharmaceuticals |
Predecessors | Allergan, Inc. and Actavis before the 2015 tax inversion and merger |
Founded | May 16, 2013; 10 years ago (2013-05-16), upon the combination of Allergan Finance, LLC (Actavis) & Warner Chilcott March 17, 2015; 9 years ago (2015-03-17) renamed to Allergan Plc upon the merger of Allergan, Inc and Actavis |
Headquarters | Clonshaugh Business & Technology Park, Coolock, D17 E400, , |
Number of locations | 40 manufacturing facilities, 27 global R&D centres and marketing/sales facilities worldwide. |
Area served | ~100 countries |
Products | Branded pharmaceuticals |
Revenue | $16.089 billion (2019) |
-$5.142 billion (2018) | |
Total assets | $94.699 billion (2019) |
Total equity | $58.195 billion (2019) |
Number of employees | 17,800 (2018) |
Parent | AbbVie |
Website | www |
Footnotes / references [1] |
Allergan plc was formed in March 2015 when Irish–registered Actavis plc acquired U.S.–registered Allergan, Inc., and assumed the Allergan name.[4][5] In 2016, Allergan sold its generic drugs business, Actavis, to Teva Pharmaceuticals for $40.5 billion.[6]
In June 2019, U.S. pharmaceutical company AbbVie announced it had reached an agreement to acquire Allergan for $63 billion. The merged company would be domiciled in the U.S. for tax purposes.[7][8]